restructuring
Apple Tree files for bankruptcy as it seeks fresh funding from Russian billionaire backer
Apple Tree; bankruptcy filing; insolvency; Russian billionaire backer; restructuring; financing deal; debt obligations; investor rescue
Novartis Announces Plans to Lay Off 550 Workers at Swiss Factory
Novartis; layoffs; Switzerland; Stein facility; pharmaceutical manufacturing; restructuring; Schweizerhalle investment
Nxera Pharma to Cut 15% of Workforce in Japan and UK as Part of Restructuring Plan
Nxera Pharma; workforce reduction; restructuring; Japan; UK; R&D operations; profitability; GPCR pipeline; organizational optimization
Merck Continues Cuts: 204 Employees Laid Off in New Jersey
Merck; layoffs; New Jersey; Rahway; pharmaceutical; cost-cutting; restructuring; WARN notice; global workforce reduction; Keytruda; Gardasil; biopharma industry
Bayer’s Pharma Division Grows as Restructuring Drives Major Changes
Bayer; pharma division; restructuring; job cuts; Dynamic Shared Ownership (DSO); sales growth; oncology; Kerendia; Nubeqa; Xarelto; management changes
Takeda Makes Pipeline Cuts and Faces Softer Q2 Sales Due to Generic Competition
Takeda; pipeline cuts; generic competition; Q2 sales; Vyvanse; restructuring; operating profit; impairment charges; drug development; late-stage pipeline
Galapagos Winds Down Cell Therapy Business After Failed Sale, Cuts 365 Jobs and Shutters Global Sites
Galapagos; cell therapy; exit; layoffs; restructuring; site closures
Cuts Continue as Novo Nordisk Restructuring Moves Forward
Novo Nordisk; Restructuring; Job Cuts; Pharmaceutical Industry
Novo Nordisk Ends Cell Therapy Research Amid Major Restructuring
Novo Nordisk; cell therapy; restructuring; job cuts; diabetes; cost-cutting; R&D strategy; biotech; obesity; partnership cancellations
Takeda to Cut 137 Staffers After Exiting Cell Therapy Research
Takeda; layoffs; cell therapy exit; biotech industry; restructuring; Massachusetts R&D; strategic portfolio reprioritization; pipeline shake-up